A group of FDA scientists has posted Bert Mandelbaum, MD, a sports medicine specialist, orthopedic surgeon, and co-director of the Regenerative Orthobiologic Center at Cedars-Sinai Orthopedics in Los Angeles, told Healthline in a recent interview that so-called wellness peptides are neither safe nor effective
In the NEJM Phase 2 trial, participants assigned to an initial dose of 4 mg experienced significantly more adverse events than those who started at 2 mg, even when both groups ultimately reached the same target dose
However, avoid excessive polypharmacy, 2-3 peptides maximum for musculoskeletal applications
The FDA committee is tasked with reviewing data that supports using these peptides for specific conditions, including migraines, ulcerative colitis, opioid withdrawal and wound healing
Reference guide for GHK-Cu 50MG protocol math